Biogen Idec to Provide Business Update at Investor Meeting.
Business Wire › January 12, 2010
Linked as:
Extract
Biogen Idec to Provide Business Update at Investor Meeting.
TYSABRI([R]) Surpasses $1 Billion in 2009 Sales as Patients on Therapy Increase 30%
Pipeline Continues to Advance, Including Fampridine EU Filing SAN FRANCISCO -- In a presentation to investors today at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, Biogen Idec (NASDAQ: BIIB) Chief Executive Officer James C. Mullen will outline the company's plan to continue to drive shareholder v...See the full content of this document
Sponsored links
